Ala. AG Loses Bid To Revive $275M AWP Cases

Law360, New York (January 22, 2010, 6:37 PM EST) -- The Alabama Supreme Court has refused to reconsider its reversal of two jury decisions that had awarded the state nearly $275 million from Novartis Pharmaceuticals Corp., GlaxoSmithKline and AstraZeneca LP, putting to rest the bellwether prescription drug price-fixing case.

In an 8-1 judgment without opinion, the high court on Friday denied Alabama Attorney General Troy King's application for rehearing and reconsideration — a ruling that could pave the way for the dismissal of 70 similar actions in state courts.

Although at trial, King had prevailed on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.